APIs and Excipients

Novo Nordisk Expands Insulin Manufacturing Facility in India

December 13, 2017

In partnership with Indian pharmaceutical firm, Torrent Pharmaceuticals, Novo Nordisk has expanded an insulin manufacturing facility at Torrent’s Indrad, Gujarat, India site.

Vertex and CRISPR Therapeutics Partner on Gene Therapy for Blood Disorders

December 13, 2017

The companies will co-develop and co-commercialize the lead candidate generated from their earlier collaboration to treat genetic blood disorders.

An Innovative Excipient System for Film Coating

December 08, 2017

The low viscosity of Colorcon’s Opadry QX, even at solid levels as high as 35%, reduces coating and preparation time compared to traditional hydroxypropyl methylcellulose-based coatings.

WuXi Biologics Starts Up Large-Scale, Single-Use Biomanufacturing Facility

December 08, 2017

The new 30,000-L, $150-million biologics manufacturing facility in Wuxi, China, quintuples the company’s existing manufacturing capability.

Gilead Sciences and Kite to Acquire Cell Design Labs

December 08, 2017

Gilead Sciences will acquire Cell Design Labs to further cell-therapy research and development efforts.

A New Efficient Synthesis of Ospemifene

December 06, 2017

The method developed by Cambrex uses standard plant equipment and requires only two synthetic steps and one recrystallization, minimizing waste and use of solvents.

AMRI Expands Bulk API Aseptic Manufacturing Capacity

December 06, 2017

The contract research, development, and manufacturing organization has expanded API aseptic manufacturing capacity at its Valladolid, Spain, facility.

Stakeholders Comment on FDA Draft Guidance for Evaluating Biosimilarity

December 05, 2017

Biopharma majors are among the industry stakeholders who have commented and raised questions about FDA’s recently proposed draft guidance for analytical assessment of similarity in biosimilars.

Hazardous Chemistry: Choosing Batch or Flow

December 02, 2017

For many processes involving hazardous chemistry, running in flow mode has safety and economic advantages.

GE Healthcare Completes Acquisition of Bioprocessing Start-Up

November 28, 2017

The acquisition gives GE Healthcare access to a nanofiber-based platform purification technology that can offer improvements in biopharmaceutical productivity.